Shoreline Biome Granted Foundational Patent for High Resolution Microbiome Analysis Technology
Share Article FARMINGTON, Conn. (PRWEB) January 26, 2021
Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, was recently awarded a new patent by the United States Patent and Trademark Office.
The patent, U.S. Patent 10,894,990, was awarded January 19, 2021, for a High Throughput Method For Identification and Sequencing of Unknown Microbial and Eukaryotic Genomes from Complex Mixtures.
The patent protects the bacterial identification method, utilizing the novel 16S-ITS-23S amplicon, found in Shoreline Biome s flagship StrainID kits. StrainID kits provide a fast, easy-to-use method for amplicon-based microbial strain identification on the PacBio Sequel long read next generation sequencing platform.